[3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine
C93H70ClF16N31O2S — CID 159001930
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine
[3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine (PubChem CID 159001930) has the molecular formula C93H70ClF16N31O2S and a molecular weight of 2025.29 g/mol. Its IUPAC name is [3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine.
Molecular Properties
| Compound Name | [3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine |
|---|---|
| PubChem CID | 159001930 |
| Molecular Formula | C93H70ClF16N31O2S |
| Molecular Weight | 2025.29 g/mol |
| Exact Mass | 2023.55 |
| IUPAC Name | [3-[4-amino-6-[4-(difluoromethoxy)anilino]-5-fluoropyrimidin-2-yl]-5-fluoropyrazolo[1,5-a]pyridin-2-yl]methanol;4-N-(4-chlorophenyl)-5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-(4-methylphenyl)pyrimidine-4,6-diamine;5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[6-(trifluoromethyl)-3-pyridinyl]pyrimidine-4,6-diamine;2-(2-methylsulfanylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine |
| SMILES | CSc1nc2ccccc2n1-c1nc(N)cc(Nc2ccc(C(F)(F)F)cc2)n1.Cc1ccc(Nc2nc(-n3c(C)nc4ccc(F)cc43)nc(N)c2F)cc1.Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)nc2)n1.Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(Cl)cc2)n1.Nc1nc(-c2c(CO)nn3ccc(F)cc23)nc(Nc2ccc(OC(F)F)cc2)c1F |
| InChI | InChI=1S/C19H14F4N6O2.C19H15F3N6S.C19H16F2N6.C18H13ClF2N6.C18H12F5N7/c20-9-5-6-29-13(7-9)14(12(8-30)28-29)17-26-16(24)15(21)18(27-17)25-10-1-3-11(4-2-10)31-19(22)23;1-29-18-25-13-4-2-3-5-14(13)28(18)17-26-15(23)10-16(27-17)24-12-8-6-11(7-9-12)19(20,21)22;1-10-3-6-13(7-4-10)24-18-16(21)17(22)25-19(26-18)27-11(2)23-14-8-5-12(20)9-15(14)27;1-9-23-13-7-4-11(20)8-14(13)27(9)18-25-16(22)15(21)17(26-18)24-12-5-2-10(19)3-6-12;1-8-26-11-4-2-9(19)6-12(11)30(8)17-28-15(24)14(20)16(29-17)27-10-3-5-13(25-7-10)18(21,22)23/h1-7,19,30H,8H2,(H3,24,25,26,27);2-10H,1H3,(H3,23,24,26,27);3-9H,1-2H3,(H3,22,24,25,26);2-8H,1H3,(H3,22,24,25,26);2-7H,1H3,(H3,24,27,28,29) |
| InChIKey | JRLDYYLXVIVFEE-UHFFFAOYSA-N |
| XLogP | 20.93 |
| TPSA | 450.08 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 144 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2025.29 |
| LogP ≤ 5 | 20.93 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159001930 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.